Federal Data Hub › SEC Fails-to-Deliver · JSON
Fails-to-deliver · CUSIP 68235J201
Over the rolling 12-month window, securities of ONCOLOGY PHARMA INC COM NEW failed to deliver in the NSCC's Continuous Net Settlement system on 8 settlement days, totaling 2,339 fail shares and peaking at 1,247 shares on 2026-03-11. Persistent or spiking fails-to-deliver can signal delivery stress, naked short selling, or operational settlement problems.
| Settlement date | Fail shares | Price |
|---|---|---|
| 2026-03-11 | 1,247 | $0.02 |
| 2026-03-10 | 15 | $0.01 |
| 2026-03-02 | 79 | — |
| 2026-02-27 | 94 | — |
| 2026-02-24 | 390 | — |
| 2026-02-23 | 364 | — |
| 2025-11-07 | 100 | — |
| 2025-10-24 | 50 | — |
A "fail-to-deliver" occurs when a party in a securities trade does not deliver the shares by the settlement date. The SEC publishes twice-monthly files of CNS fails-to-deliver by security. This page aggregates the rolling 12-month window. CUSIP 68235J201 links to this security's other federal filings across the hub.
Source: SEC Fails-to-Deliver Data. License: CC0 1.0.